Insider Transactions in Q2 2023 at Xenon Pharmaceuticals Inc. (XENE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2023
|
Simon N. Pimstone |
SELL
Open market or private sale
|
Direct |
31,713
-67.79%
|
$1,205,094
$38.88 P/Share
|
|
Jun 01
2023
|
Simon N. Pimstone |
SELL
Payment of exercise price or tax liability
|
Direct |
22,605
-26.41%
|
$858,990
$38.53 P/Share
|
|
Jun 01
2023
|
Simon N. Pimstone |
BUY
Exercise of conversion of derivative security
|
Direct |
54,318
+42.35%
|
$651,816
$12.73 P/Share
|
|
May 31
2023
|
Simon N. Pimstone |
SELL
Open market or private sale
|
Direct |
62,526
-76.06%
|
$2,375,988
$38.68 P/Share
|
|
May 31
2023
|
Simon N. Pimstone |
SELL
Payment of exercise price or tax liability
|
Direct |
29,309
-29.27%
|
$1,113,742
$38.37 P/Share
|
|
May 31
2023
|
Simon N. Pimstone |
BUY
Exercise of conversion of derivative security
|
Direct |
79,835
+46.3%
|
$1,037,855
$13.81 P/Share
|
|
May 30
2023
|
Simon N. Pimstone |
SELL
Open market or private sale
|
Direct |
37,006
-42.04%
|
$1,443,234
$39.27 P/Share
|
|
May 24
2023
|
Ian Mortimer PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
31,655
-25.96%
|
$1,297,855
$41.43 P/Share
|
|
May 24
2023
|
Ian Mortimer PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,383
-9.07%
|
$507,703
$41.84 P/Share
|
|
May 24
2023
|
Ian Mortimer PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
69,340
+31.2%
|
$624,060
$9.71 P/Share
|